|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2010-10-25
|
|
pubmed:abstractText |
Women with breast cancer that initially involves local lymph nodes have a higher risk for local recurrence or developing metastases. Recent data suggest that germline polymorphism is a significant, previously unrecognized factor in breast cancer progression and metastasis. We assessed the influence of 16 selected common germline polymorphisms in disease-free survival and overall survival among 216 women diagnosed with lymph node-positive breast cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
1432-1335
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
136
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1813-9
|
|
pubmed:meshHeading |
pubmed-meshheading:20204402-Adult,
pubmed-meshheading:20204402-Aged,
pubmed-meshheading:20204402-Aged, 80 and over,
pubmed-meshheading:20204402-Antigens, CD95,
pubmed-meshheading:20204402-Breast Neoplasms,
pubmed-meshheading:20204402-Disease Progression,
pubmed-meshheading:20204402-Disease-Free Survival,
pubmed-meshheading:20204402-Female,
pubmed-meshheading:20204402-Gene Frequency,
pubmed-meshheading:20204402-Genetic Predisposition to Disease,
pubmed-meshheading:20204402-Genotype,
pubmed-meshheading:20204402-Germ-Line Mutation,
pubmed-meshheading:20204402-Humans,
pubmed-meshheading:20204402-Interleukin-10,
pubmed-meshheading:20204402-Lymph Nodes,
pubmed-meshheading:20204402-Lymphatic Metastasis,
pubmed-meshheading:20204402-Middle Aged,
pubmed-meshheading:20204402-Multivariate Analysis,
pubmed-meshheading:20204402-Neoplasm Staging,
pubmed-meshheading:20204402-Polymorphism, Single Nucleotide,
pubmed-meshheading:20204402-Prognosis
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Analysis of common germline polymorphisms as prognostic factors in patients with lymph node-positive breast cancer.
|
|
pubmed:affiliation |
Department of Internal Medicine, Division of Oncology, Medical University Graz, Auenbruggerplatz 15, 8036 Graz, Austria.
|
|
pubmed:publicationType |
Journal Article
|
